| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
5 companies
Casdin Partners Master Fund, L.P. serves as a Director, 10% Owner at LAB and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 69 buys and 9 sells. Those positions are worth an estimated $283.0M at current prices.
Historically, Casdin Partners Master Fund, L.P.'s trades have earned a middling insider score of 53/100 across 68 rated trades. Over a 12-month horizon, 29.3% of those trades were profitable, with an average 12-month return of -21.4%.
The biggest single holding is BLFS (~$164.9M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 2,197,166 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2019 | BLFS Biolife Solutions Inc | 10% Owner | Buy | 40,000 | $15.41 | $616,536.00 | +0.8% |